representing a diverse ecosystem of industrial players, major groups, SMEs, start-ups, research laboratories, university teaching hospitals, universities, and specialized educational institutions. Together, they create a dynamic, competitive ecosystem for healthcare innovations, spanning biomedicine, MedTech, digital health, and disease prevention, with a focus on advancing cutting-edge solutions across these sectors. 

Atlanpole Biotherapies leverages its strong regional presence, global ambitions, and collaborative approach to support a wide range of healthcare innovations, from the initial concept and development of new products to their application, scaling, and global commercialization. Through its international strategy, Atlanpole is building partnerships with other healthcare clusters to drive growth, foster collaborative R&D, and increase global influence in the service of a high-quality healthcare sector. 

This approach aims to stimulate innovation at the intersection of disciplines such as Pharma/Biotech, TechBio & AI, Quantum as enabling techno to serve the following sub sectors as well as MedTech & Diagnostics, Robotics and Medical Equipment, Food & Agri6Tech and Cosmetics.

Team France Export – the French public initiative supporting the internationalization of French companies – , CCI International Grand Est provides tailored solutions to meet the needs of companies seeking to expand internationally.
Its team of advisors, in collaboration with Business France, supports companies at every stage of their international development.

world, while ensuring the Region’s sustainable and balanced development.

research institutes, hospitals, and expert organisations supporting innovators across the full innovation lifecycle.

Eurobiomed bridges clinical and digital health strengths across two complementary regions: Région Sud (immunotherapies, dermatology, AI in health) and Occitanie (biotherapies, diagnostics, biomanufacturing). These ecosystems rely on strong collaboration between academia, healthcare providers, industry, and public authorities, supported by leading universities, hospitals, research infrastructures, and accelerators.

As a partner, Eurobiomed brings critical mass, strong deal flow, EU and France 2030 funding expertise, and hands-on support in regulatory, clinical, industrialisation, investment readiness, and health-sector specialised support for EU and global entrepreneurs and partners. Eurobiomed anchors projects in regional innovation ecosystems to ensure strong European impact, scalability, and long-term sustainability.

for public authorities in France and Europe, France Biotech helps address the major challenges facing the HealthTech sector (including company financing, innovation taxation, regulatory and market access issues, etc.). Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry.

Its objective is to support HealthTech startups and SMEs in becoming successful international companies capable of designing and developing innovative products and solutions rapidly and ultimately making them accessible to patients.

investors, laboratories, and corporates.

to jointly promote their activities, expertise, technologies and innovations internationally. It helps to trigger a collective approach dynamic that stimulates international cooperation in the field of health and to promote the vision that health, a vector of social progress, must be improved for everyone everywhere in the world.

outreach, recruitment, implantation and more

talent from around the globe.

and technological solutions. Certified by the French government under the France 2030 plan, GenoTher provides access to cutting-edge platforms, contributes to training the next generation of talent, and supports the growth of high-potential companies.

The Southern California French American Chamber of Commerce is proud to establish La French Tech San Diego. This milestone reinforces the entrepreneurial bond between France and San Diego, fostering innovation, creating opportunities, and shaping a remarkable future for startups and tech companies in our vibrant city.

global healthcare challenges. With over 250 members, including world-class leaders, innovative SMEs, and research centers, Lyonbiopole fosters collaboration and development of breakthrough healthTech innovations to the benefit of patients.

opportunities for its 300, and growing, members. All and every action from MabDesign is based on their expertise in the biotherapy and bioproduction field.